Recruiting Von Willebrand Disease Studies in Minneapolis
About Von Willebrand Disease Clinical Trials in Minneapolis
Von Willebrand disease is the most common inherited bleeding disorder, caused by deficiency or dysfunction of von Willebrand factor, a protein needed for blood clotting. Most cases are mild with excessive bleeding during surgery or dental work. Treatment includes desmopressin and von Willebrand factor concentrates.
There are currently 1 von willebrand disease clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 24 participants. Research is being sponsored by Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Von Willebrand Disease Clinical Trials in Minneapolis — FAQ
Are there von willebrand disease clinical trials in Minneapolis?
Yes, there are 1 von willebrand disease clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Minneapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.
Are clinical trials in Minneapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.
What von willebrand disease treatments are being tested?
The 1 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for von willebrand disease.
Data updated March 2, 2026 from ClinicalTrials.gov